연구

주저자

2026 Jan

Aspirin and 간세포암(HCC) risk in 대사이상지방간질환(MASLD): Nationwide cohort study with genetic risk analysis

Ahn J, Hur MH, Shin H, Park MK, Won S, Park J, Ko Y, Park Y, Lee YB, Cho EJ, Lee JH, Yu SJ, Yoon JH, Kim YJ

Clin Mol Hepatol · 2026 · 32(1):339-352

2026 Jan

Adjuvant cytokine-induced killer cell immunotherapy in hepatocellular carcinoma: real-world data and 9-year extended follow-up of a randomized controlled trial

Shin H, Park Y, Song BG, Choi WM, Han HJ, Lee Y, Song TJ, Yeon JE, Lim YS, Hur MH, Lee YB, Cho EJ, Yu SJ, Kim YJ, Lee JH, Yoon JH, Lee JH

Cancer Immunol Immunother · 2026 · 75(2):55

DOI · PMID 41591582

2026 Apr

Efficacy and Safety of Switching from Entecavir to Tenofovir Alafenamide in Chronic Hepatitis B: A Multicenter Randomized Trial in Korea

Shin H, Hur MH, Baek YH, Lee CK(크레아틴 키나아제), Cho YK, Lee JS, Jeong JY, Jung YJ, Kim JK, Kim MY, Seo YS, Chung WJ, Koh MS, Kim J, Lee YB, Cho EJ, Lee J, Yu SJ, Yoon J, Kim YJ

Gut Liver · 2026 · (ahead of print)

DOI · PMID 42015653

2025 Mar

A concise review of updated global guidelines for the management of hepatocellular carcinoma: 2017-2024

Shin H, Yu SJ

J Liver Cancer · 2025 · 25(1):19-30

DOI · PMID 39925090

2025 Jun

AI model using CT(컴퓨터 단층촬영)-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B

Shin H, Hur MH, Song BG, Park SY, Kim GA, Choi GH, Nam JY, Kim MA, Park Y, Ko Y, Park J, Lee HA, Chung SW, Choi NR, Park MK, Lee YB, Sinn DH, Kim SU, Kim HY, Kim JM, Park SJ, Lee HC, Lee DH, Chung JW, Kim YJ, Yoon JH, Lee JH

J Hepatol · 2025 · 82(6):1080-1088

DOI · PMID 39710148

2024 Feb

Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: a real-world multicenter cohort study

Shin H, Kim SU, Song BG, Park Y, Ko Y, Park J, Hur MH, Lee YB, Cho EJ, Lee JH, Yu SJ, Yoon JH, Sinn DH, Kim YJ

Hepatol Res · 2024 · 54(7):627-637

DOI · PMID 38300711

2024 Jul

Metabolic Effects and Cardiovascular Disease Risks of Antiviral Treatments in Patients with Chronic Hepatitis B

Shin H, Lim GS, Yoon JW, Ko Y, Park Y, Park J, Hur MH, Park MK, Cho Y, Lee YB, Cho EJ, Kim BH, Lee JH, Yu SJ, Yoon JH, Kim YJ

J Med Virol · 2024 · 96(7):e29760

DOI · PMID 38940453

2024 Jul

Lack of Association between Early On-Treatment HBeAg-Seroclearance and Development of Hepatocellular Carcinoma or Decompensated Liver Cirrhosis

Shin H, Choi WM, Kim SU, Ko Y, Park Y, Park J, Hur MH, Park MK, Lee YB, Kim YJ, Yoon JH, Lee JH, Zoulim F

JHEP Rep · 2024 · 6(7):101089

DOI · PMID 38974365

2024 Sep

Inhibition of sodium-glucose cotransporter-2 and liver-related complications in individuals with diabetes: A mendelian randomization and population-based cohort study

Chung SW, Moon HS, Shin H, Han H, Park S, Cho H, Park J, Hur MH, Park MK, Won SH, Lee YB, Cho EJ, Yu SJ, Kim DK, Yoon JH, Lee JH, Kim YJ

Hepatology · 2024 · 80(3):633-648

DOI · PMID 38466796

2023 Oct

COVID-19 Vaccination Alters NK Cell Dynamics and Transiently Reduces HBsAg Titers Among Patients With Chronic Hepatitis B

Shin H, Lee HS, Noh JY, Koh JY, Kim SY, Park J, Chung SW, Hur MH, Park MK, Lee YB, Kim YJ, Yoon JH, Ko JH, Peck KR, Song JY, Shin EC, Lee JH

Immune Netw · 2023 · 23(5):e39

DOI · PMID 37970236

공저자

2025 Feb

A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B

Hur MH, Yip TC, Kim SU, Lee HW, Lee HA, Lee HA, Lee HC, Wong GL, Wong VW, Park JY, Ahn SH, Kim BK, Kim HY, Seo YS, Shin H, Park J, Ko Y, Park Y, Lee YB, Yu SJ, Lee SH, Kim YJ, Yoon JH, Lee JH

J Hepatol · 2025 · 82(2):235-244

DOI · PMID 39218223

2025 Mar

Hepatocellular Carcinoma in Korea: An Analysis of the 2016-2018 Korean Nationwide Cancer Registry

An J, Chang Y, Choi GH, Sohn W, Son JE, Shin H, Yoon JH, Yoon JS, Jang HY, Cho EJ, Han JW, Hong SK, Cho JY, Jung KW, Park EH, Kim E, Kim BH

J Liver Cancer · 2025 · 25(1):109-122

DOI · PMID 40033636

2025 Jun

Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis

Ko Y, Song BG, Shin H, Park Y, Park J, Park MK, Lee YB, Yu SJ, Sinn DH, Kim YJ, Yoon JH, Park SS, Hur MH, Lee JH

Osteoporos Int · 2025 · 36(11):2349

DOI · PMID 40844610

2025 Jul

Comparison of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Steatotic Liver Disease

Ko Y, Hur MH, Park Y, Park J, Shin H, Lee YB, Cho EJ, Lee JH, Yu SJ, Yoon JH, Kim YJ

Gut Liver · 2025 · 19(5):758-769

DOI · PMID 40675923

2025 Sep

Transarterial radioembolization versus atezolizumab-bevacizumab for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis

Park Y, Cho Y, Kim SU, Kim A, Shin H, Kim HC, Lee IJ, Kim GM, Hyun D, Ko Y, Park J, Yoon JW, Lim GS, Hur MH, Lee YB, Cho EJ, Lee JH, Yu SJ, Yoon JH, Chung JW, Sinn DH, Kim YJ

Diagn Interv Imaging · 2025 · 107(1):25-37

DOI · PMID 40998641

2025 Oct

The Liver Week 2025 Highlights: Celebrating the 30th Anniversary of the Korean Association for the Study of the Liver

Chon YE, Shim JH, Oh JH, Yang J, Shin H, Kang W, Hwang Y, Yu SJ, Kim J, Lee HW, Kim YJ, Jeong SH

Clin Mol Hepatol · 2025 · 31(4):1107-1114

DOI · PMID 41111276

2024 Jan

Extrahepatic malignancies in metabolic dysfunction-associated fatty liver disease: A nationwide cohort study

Park MK, Hur MH, Moon HS, Shin H, Chung SW, Won S, Lee YB, Cho EJ, Lee JH, Yu SJ, Yoon JH, Kim YJ

Liver Int · 2024 · 44(3):799-810

DOI · PMID 38230848

2024 May

Extrahepatic Malignancies and Antiviral Drugs for Chronic Hepatitis B: A Nationwide Cohort Study

Hur MH, Lee DH, Lee JH, Kim MS, Park J, Shin H, Chung SW, Cho HJ, Park MK, Jang H, Lee YB, Yu SJ, Lee SH, Jung YJ, Kim YJ, Yoon JH

Clin Mol Hepatol · 2024 · 30(3):500-514

DOI · PMID 38726505

2024 Jun

Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis

Hwang J, Hwang H, Shin H, Kim BH, Kang SH, Yoo JJ, Choi MY, Lee D, Jun DW, Cho Y

Clin Mol Hepatol · 2024 · 30(3):561-576

DOI · PMID 38830642

2024 Dec

Role and Effectiveness of Hypofractionated Proton Beam Therapy and Combinations with Systemic Chemotherapy in Inoperable Extrahepatic Cholangiocarcinoma

Lee SU, Kim TH, Woo SM, Chun JW, Shin H, Cho Y, Kim BH, Koh YH, Kim SS, Suh YG, Moon SH, Lee WJ

Cancer Res Treat · 2024 · 57(3):852-864

DOI · PMID 39701089

2023 Feb

Transarterial chemoembolization as an alternative to radioembolization is associated with earlier tumor recurrence than in radioembolization-eligible patients

Chung SW, Cho H, Shin H, Park J, Kim JY, Hong JH, Hur MH, Park MK, Lee YB, Yu SJ, Lee M, Kim YJ, Paeng JC, Yoon JH, Chung JW, Lee JH, Kim HC

Front Oncol · 2023 · 13:1081479

DOI · PMID 36925930

2023 Jul

Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma

Park J, Chung SW, Lee YB, Shin H, Hur MH, Cho H, Park MK, Youk J, Lee JY, Lee JO, Yu SJ, Kim YJ, Yoon JH, Kim TM, Lee JH

Clin Mol Hepatol · 2023 · 29(3):794-809

DOI · PMID 37196991

2023 Dec

Comparison of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosis

Park J, Lee YB, Ko Y, Park Y, Shin H, Hur MH, Park MK, Lee DW, Cho EJ, Lee KH, Lee JH, Yu SJ, Kim TY, Kim YJ, Kim TY, Yoon JH

J Liver Cancer · 2023 · 24(1):81-91

DOI · PMID 38246747

2022 Jul

Correlation between Results of Semi-Quantitative and Quantitative Tests for Hepatitis B Virus Surface Antigen among Patients Achieving Viral Suppression with Antiviral Treatment

Chung GE, Kim JY, Shin H, Hong JH, Hur MH, Cho H, Park MK, Choi NR, Kim J, Lee YB, Cho EJ, Yu SJ, Kim YJ, Yoon JH, Lee JH

Diagnostics · 2022 · 12(7):1757

DOI · PMID 35885659

기타

2024 Aug

Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial

Shin H, Lee JH

Lancet · 2024 · 404(10453):654-655

DOI · PMID 39153810

인용은 원 출처(저널·DOI)를 따라주시기 바랍니다.